B. Fischer

发表

Modelling the P2Y purinoceptor using rhodopsin as template.

K. Jacobson, A. V. van Rhee, B. Fischer, 1995, Drug design and discovery.

Molecular recognition in purinergic receptors. 2. Diastereoselectivity of the h-P2Y1-receptor.

D. Major, G. Reiser, B. Fischer, 2004, Journal of medicinal chemistry.

Molecular recognition in purinergic receptors. 1. A comprehensive computational study of the h-P2Y1-receptor.

D. Major, B. Fischer, 2004, Journal of medicinal chemistry.

Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis.

G. Reiser, B. Fischer, Jacques Zylberg, 2007, The Biochemical journal.

A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist

D. Major, M. Dixit, J. Pintor, 2018, Purinergic Signalling.

Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by the Cu(II)-Prion Peptide Complex.

L. Shimon, L. Casella, Naomi Levy, 2019, Inorganic chemistry.

Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypes

G. Burnstock, K. Jacobson, T. K. Harden, 1994 .

(Aminomethylene)phosphonate Analogues as ZnII Chelators: Synthesis and Characterization

H. Gottlieb, B. Fischer, Thomas Jantz, 2017 .

Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.

G. Reiser, B. Fischer, M. Haas, 2013, Biochemical pharmacology.

Addressing regio- and stereo-specificity challenges in the synthesis of nucleoside 2',3'-cyclic monophosphate analogs - a rapid and facile synthesis of nucleoside-2',3'-O,O-phosphoro-thioate or -selenoate, and elucidation of the origin of the rare specificity.

B. Fischer, Molhm Nassir, Lara Balaom, 2020, Chemical communications.

Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.

B. Fischer, Rozena Baruch-Suchodolsky, 2008, Biochemistry.

Detection of mRNA of the cyclin D1 breast cancer marker by a novel duplex-DNA probe.

Y. Shav-Tal, E. Yavin, B. Fischer, 2013, Journal of medicinal chemistry.

Rules for the design of highly fluorescent nucleoside probes: 8-(substituted cinnamyl)-adenosine analogues.

D. Major, M. Weitman, B. Fischer, 2013, The Journal of organic chemistry.

Analogues of uracil nucleosides with intrinsic fluorescence (NIF-analogues): synthesis and photophysical properties.

B. Fischer, Meirav Segal, 2012, Organic & biomolecular chemistry.

Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

X. Ji, N. Melman, B. Fischer, 1994, Journal of medicinal chemistry.

Detection of cyclin D1 mRNA by hybridization sensitive NIC-oligonucleotide probe.

Y. Shav-Tal, E. Yavin, B. Fischer, 2014, Bioorganic & medicinal chemistry.

Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists.

G. Reiser, B. Fischer, D. Förster, 2013, Journal of medicinal chemistry.

8‐BuS‐ATP derivatives as specific NTPDase1 inhibitors

J. Brosseau, B. Künzli, É. Rousseau, 2013, British journal of pharmacology.

Oligonucleotides are potent antioxidants acting primarily through metal ion chelation

H. Gottlieb, E. Yavin, B. Fischer, 2010, JBIC Journal of Biological Inorganic Chemistry.

Phenyl-imidazolo-cytidine analogues: structure-photophysical activity relationship and ability to detect single DNA mismatch.

D. Major, M. Weitman, B. Fischer, 2014, The Journal of organic chemistry.

Molecular Recognition of Adenosine Deaminase: 15N NMR Studies

H. Gottlieb, B. Fischer, A. Laxer, 2007, Nucleosides, nucleotides & nucleic acids.

A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.

J. Camden, G. Weisman, H. Barr, 2010, Journal of medicinal chemistry.

Identification of hydrolytically stable and selective P2Y(1) receptor agonists.

J. Sévigny, J. Lecka, J. Camden, 2009, European journal of medicinal chemistry.

Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.

B. Fischer, Rozena Baruch-Suchodolsky, 2009, Biochemistry.

Department of Chemistry, Bar‐Ilan University (BIU)

Y. Mastai, A. Nudelman, B. Fischer, 2014 .

5-OMe-uridine-5′-O-(α-boranodiphosphate), a novel nucleotide derivative highly active at the human P2Y6 receptor protects against death-receptor mediated glial apoptosis

G. Reiser, B. Fischer, Tamar Ginsburg-Shmuel, 2014, Neuroscience Letters.

Acetyl Chloride-Methanol as a Convenient Reagent for: A) Quantitative Formation of Amine Hydrochlorides B) Carboxylate Ester Formation C) Mild Removal of N-t-Boc-Protective Group.

A. Nudelman, B. Fischer, E. Falb, 1998 .

"Cleavable trifunctional" approach to receptor affinity labeling: chemical regeneration of binding to A1-adenosine receptors.

K. Jacobson, X. Ji, B. Fischer, 1995, Bioconjugate chemistry.

5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.

G. Reiser, B. Fischer, Tamar Ginsburg-Shmuel, 2010, Journal of Medicinal Chemistry.

Comparative studies on the affinities of ATP derivatives for P2X‐purinoceptors in rat urinary bladder

G. Burnstock, K. Jacobson, B. Fischer, 1994, British journal of pharmacology.

Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.

G. Reiser, J. Sévigny, S. Lévesque, 2006, Journal of medicinal chemistry.

Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.

G. Reiser, S. Lévesque, B. Fischer, 2002, Journal of medicinal chemistry.

Studies in sugar chemistry. 2. A simple method for O-deacylation of polyacylated sugars

H. Gottlieb, A. Nudelman, B. Fischer, 1986 .

Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonists.

J. Sévigny, J. Lecka, B. Fischer, 2015, Bioorganic & medicinal chemistry.

2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.

A. Chulkin, B. Fischer, J. Boyer, 1999, The Israel Medical Association journal : IMAJ.

Identification of potent P2Y‐purinoceptor agonists that are derivatives of adenosine 5′‐monophosphate

K. Jacobson, T. K. Harden, S. Siddiqi, 1996, British journal of pharmacology.

Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.

G. Burnstock, K. Jacobson, T. K. Harden, 1993, Journal of medicinal chemistry.

2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.

J. Sévigny, J. Lecka, J. Camden, 2010, Journal of medicinal chemistry.

Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.

D. Major, G. Reiser, B. Fischer, 1999, Journal of medicinal chemistry.

Potent agonist action of 2‐thioether derivatives of adenine nucleotides at adenylyl cyclase‐linked P2y‐purinoceptors

K. Jacobson, T. K. Harden, B. Fischer, 1995, British journal of pharmacology.

Fluorescent p-substituted-phenyl-imidazolo-cytidine analogues

B. Fischer, M. Kovaliov, Meirav Segal, 2013 .

Nucleoside 5′-Phosphorothioate Derivatives as Oxidative Stress Protectants in PC12 Cells

B. Fischer, S. Grossman, O. Danino, 2013, Nucleosides, nucleotides & nucleic acids.

P2‐receptor agonists: From molecular recognition studies to potential clinical applications

B. Fischer, 2000 .

Therapeutic applications of ATP-(P2)-receptors agonists and antagonists

B. Fischer, 1999 .

Diastereoselectivity of the P2Y11 nucleotide receptor: mutational analysis

G. Reiser, B. Fischer, D. Ecke, 2008, British journal of pharmacology.

Hydrolytic (in)stability of phosphate isosteres.

B. Fischer, Molhm Nassir, Avinoam Isaak, 2022, European journal of medicinal chemistry.

UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.

G. Reiser, Djordje Grbic, B. Fischer, 2012, Bioorganic & medicinal chemistry.

Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5′‐O‐(α‐boranotriphosphate) analogues

G. Reiser, B. Fischer, V. Nahum, 2006, British journal of pharmacology.

Novel crown-ether-methylenediphosphonotetrathioate hybrids as Zn(II) chelators.

H. Gottlieb, L. Shimon, B. Fischer, 2015, Dalton transactions.

Studies of Mg2+/Ca2+ complexes of naturally occurring dinucleotides: potentiometric titrations, NMR, and molecular dynamics

D. Major, H. Gottlieb, B. Fischer, 2012, JBIC Journal of Biological Inorganic Chemistry.

Photoaffinity labeling on magnetic microspheres (PALMm) methodology for topographic mapping: preparation of PALMm reagents and demonstration of biochemical relevance.

S. Margel, S. Lévesque, B. Fischer, 2003, Organic & biomolecular chemistry.

2-MeS-β,γ-CCl2-ATP is a Potent Agent for Reducing Intraocular Pressure†

J. Sévigny, J. Lecka, J. Camden, 2015 .

An Improved One-Pot Synthesis of Nucleoside 5′-Triphosphate Analogues

B. Fischer, Irina Gillerman, 2010, Nucleosides, nucleotides & nucleic acids.

DIETHYL CHLOROPHOSPHITE : A MILD REAGENT FOR EFFICIENT REDUCTION OF NITRO COMPOUNDS TO AMINES

B. Fischer, L. Sheihet, 1998 .

The Synthesis of Nucleoside 2′,3′‐Cyclic Monophosphate Analogs with Regio‐ and Stereospecificity

B. Fischer, Molhm Nassir, Abed Saady, 2021, Current protocols.

Adenosine/guanosine-3',5'-bis-phosphates as biocompatible and selective Zn2+-ion chelators. Characterization and comparison with adenosine/guanosine-5'-di-phosphate.

D. Major, B. Fischer, Alexandra Vardi-Kilshtain, 2015, Dalton transactions.

Characterization of complexes of nucleoside-5'-phosphorothioate analogues with zinc ions.

B. Fischer, Y. Nadel, Noa Stern, 2013, Inorganic chemistry.

Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.

K. Jacobson, A. V. van Rhee, B. Fischer, 1995, Life sciences.

Synthesis and evaluation of a photoresponsive quencher for fluorescent hybridization probes.

E. Yavin, Chaim Wachtel, B. Fischer, 2014, Organic & biomolecular chemistry.

Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations.

B. Fischer, F. Gendron, P. D'Orléans-Juste, 2000, Journal of medicinal chemistry.

β-Cyanuryl Ribose, β-Barbituryl Ribose, and 6-Azauridine as Uridine Mimetics

H. Gottlieb, Michal Afri, B. Fischer, 2020, ACS omega.

Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors.

B. Fischer, Irina Gillerman, 2011, Journal of medicinal chemistry.

O,O'-Diester methylenediphosphonotetrathioate: synthesis, characterization, and potential applications.

L. Shimon, B. Fischer, A. Amir, 2013, The Journal of organic chemistry.

Do oxazoliks undergo Diels-Alder reactions with heterodienophiles?

B. Fischer, A. Hassner, 1989 .

Can nucleotides prevent Cu-induced oxidative damage?

B. Fischer, Rozena Baruch-Suchodolsky, 2008, Journal of inorganic biochemistry.

A novel method for stereoselective glucuronidation

E. Keinan, H. Gottlieb, A. Nudelman, 1984 .

Diethyl chlorophosphite: a versatile reagent.

B. Fischer, Z. Jie, Vebumani Rammoorty, 2002, The Journal of organic chemistry.

Pharmacological evaluation and chemical stability of 2‐benzylthioether‐5′‐O‐(1‐thiotriphosphate)‐adenosine, a new insulin secretagogue acting through P2Y receptors

A. Chulkin, N. Linck, B. Fischer, 2001 .

2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors.

A. Chulkin, B. Fischer, J. Boyer, 1999, Journal of Medicinal Chemistry.

(15N5)-Labeled Adenine Derivatives: Synthesis and Studies of Tautomerism by 15N NMR Spectroscopy and Theoretical Calculations

Dan Thomas Major, D. Major, B. Fischer, 2001 .

((15)N(5))-labeled adenine derivatives: synthesis and studies of tautomerism by (15)N NMR spectroscopy and theoretical calculations.

D. Major, H. Gottlieb, B. Fischer, 2001, The Journal of organic chemistry.

4,5- and 2,5-additions to oxazoles

B. Fischer, A. Hassner, 1989 .

Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.

J. Camden, G. Weisman, B. Fischer, 2012, Journal of medicinal chemistry.

Nucleotides and inorganic phosphates as potential antioxidants

Y. Richter, B. Fischer, 2006, JBIC Journal of Biological Inorganic Chemistry.

Characterization and Elucidation of Coordination Requirements of Adenine Nucleotides Complexes with Fe(II) Ions

Y. Richter, B. Fischer, 2003, Nucleosides, nucleotides & nucleic acids.

Adenine-(methoxy)-ethoxy-Pα,α-dithio-triphosphate inhibits pathologic calcium pyrophosphate deposition in osteoarthritic human chondrocytes.

C. Müller, J. Sévigny, J. Pelletier, 2019, Organic & biomolecular chemistry.

Nucleoside-2',3'/3',5'-bis(thio)phosphate analogues are promising antioxidants acting mainly via Cu+/Fe2+ ion chelation.

B. Fischer, Bosmat Levi Hevroni, A. Sayer, 2014, Inorganic chemistry.

What is the conformation of physiologically-active dinucleoside polyphosphates in solution? Conformational analysis of free dinucleoside polyphosphates by NMR and molecular dynamics simulations.

D. Major, H. Gottlieb, B. Fischer, 2010, Organic & biomolecular chemistry.

Nucleoside-(5'→P) methylenebisphosphonodithioate analogues: synthesis and chemical properties.

J. Sévigny, J. Lecka, B. Fischer, 2013, The Journal of organic chemistry.

Methylenediphosphonotetrathioate: synthesis, characterization, and chemical properties.

B. Fischer, A. Amir, A. Sayer, 2013, Inorganic chemistry.

Fluorescent epsilon-ATP analogues for probing physicochemical properties of proteins. Synthesis, biochemical evaluation, and sensitivity to properties of the medium.

G. Reiser, S. Lévesque, B. Fischer, 2004, Bioorganic & medicinal chemistry.

Fluorescent N2,N3‐ε‐Adenine Nucleoside and Nucleotide Probes: Synthesis, Spectroscopic Properties, and Biochemical Evaluation

G. Reiser, J. Sévigny, M. Munkonda, 2006 .

Development of fluorescent double-strand probes labeled with 8-(p-CF3-cinnamyl)-adenosine for the detection of cyclin D1 breast cancer marker.

Y. Shav-Tal, E. Yavin, B. Fischer, 2014, European journal of medicinal chemistry.

8-(p-CF3-cinnamyl)-modified purine nucleosides as promising fluorescent probes.

Alon Silberman, B. Fischer, L. Zilbershtein, 2011, Organic & biomolecular chemistry.

Novel ATP Agonists Reveal Receptor Heterogeneity Within P2X and P2Y Subtypes

G. Burnstock, K. Jacobson, B. Fischer, 1995 .

Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.

H. Senderowitz, J. Sévigny, J. Pelletier, 2013, Journal of medicinal chemistry.

Synthesis, Mechanism and Fluorescence Properties of 8-(Aryl)-3-β-D-Ribofuranosylimidazo[2,1-i]purine 5′-Phosphate Derivatives

B. Fischer, F. Gendron, A. Beaudoin, 2000, Nucleosides, nucleotides & nucleic acids.

Inhibitors of NTPDase: key players in the metabolism of extracellular purines.

B. Fischer, F. Gendron, A. Beaudoin, 2000, Advances in experimental medicine and biology.

Cycloadditions. 50. Multipath reactions between intramolecularly formed oxazolium salts and nucleophiles

B. Fischer, A. Hassner, 1992 .

Intramolecular formation of oxazolium salts and their reaction with N- and C-nucleophiles.

B. Fischer, A. Hassner, 1990 .

Rules of Chemospecificity of Nucleophilc Ring-opening of Dithia-/Oxathia-Phospholane Towards the Selective Synthesis of Nucleoside 5’-O-Pα-Thio/Dithio/Trithio-Phosphate Ester Conjugates

M. Weitman, B. Fischer, Molhm Nassir, 2021 .

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.

K. Jacobson, A. V. van Bergen, Y. Karton, 1993, Journal of medicinal chemistry.

Protonation studies of modified adenine and adenine nucleotides by theoretical calculations and (15)N NMR.

D. Major, B. Fischer, A. Laxer, 2002, The Journal of organic chemistry.

Nucleoside 5'-phosphorothioate derivatives are highly effective neuroprotectants.

N. Giladi, B. Fischer, S. Grossman, 2014, Biochemical pharmacology.

Synthesis of 2′‐Deoxyuridine Modified with a 3,5‐Difluoro‐4‐Methoxybenzylidene Imidazolinone Derivative for Incorporation into Oligonucleotide Probes for Detection of HER2 Breast Cancer Marker

B. Fischer, Noam Y. Steinman, C. Ducho, 2020, Current protocols in nucleic acid chemistry.

Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug

N. Snir, B. Fischer, U. Arad, 2018, Rheumatology.

Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold.

H. Senderowitz, N. Khazanov, J. Sévigny, 2019, European journal of medicinal chemistry.

Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes

J. Sévigny, J. Pelletier, B. Fischer, 2019, Purinergic Signalling.

Correction to: Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes

C. Müller, J. Sévigny, J. Pelletier, 2019, Purinergic Signalling.

Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes

C. Müller, J. Sévigny, J. Pelletier, 2019, Purinergic Signalling.

Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

H. Senderowitz, G. Reiser, J. Sévigny, 2014, Journal of medicinal chemistry.

Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.

G. Reiser, J. Sévigny, S. Lévesque, 2010, Journal of medicinal chemistry.

ATP-γ-S-(α,β-CH2) protects against oxidative stress and amyloid beta toxicity in neuronal culture.

B. Fischer, S. Grossman, O. Danino, 2015, Biochemical and biophysical research communications.

A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist

D. Major, M. Youdim, M. Dixit, 2018, Purinergic Signalling.

Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.

J. Camden, G. Weisman, H. Barr, 2012, Journal of medicinal chemistry.

Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5′‐O‐(1‐boranotriphosphate) derivatives

G. Reiser, B. Fischer, V. Nahum, 2004, British journal of pharmacology.

Novel modified adenosine 5'-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: Biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation.

G. Reiser, R. Schäfer, C. Vöhringer, 2001, Biochemical pharmacology.

A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.

D. Offen, B. Fischer, Y. Barhum, 2017, Journal of Alzheimer's disease : JAD.

Nucleoside-2',3'/3',5'-bis(thio)phosphate antioxidants are also capable of disassembly of amyloid beta42-Zn(ii)/Cu(ii) aggregates via Zn(ii)/Cu(ii)-chelation.

D. Major, S. Das, M. Dixit, 2016, Organic & biomolecular chemistry.

Synthesis and Photophysical Properties of Conjugates of Green Fluorescent Protein (GFP) Chromophore and 2'-Deoxy-Uridine Developed as Labelled Building Blocks for Oligonucleotide Probes

B. Fischer, Abed Saady, 2019, Journal of Pharmacy and Pharmacology.

Specific, sensitive, and quantitative detection of HER-2 mRNA breast cancer marker by fluorescent light-up hybridization probes.

Y. Shav-Tal, N. Kinor, Eli Varon, 2020, Bioconjugate chemistry.

An oligonucleotide probe incorporating the chromophore of green fluorescent protein is useful for the detection of HER-2 mRNA breast cancer marker.

Y. Shav-Tal, Eli Varon, B. Fischer, 2019, European journal of medicinal chemistry.

2-Hexylthio-β,γ-CH2-ATP is an effective and selective NTPDase2 inhibitor.

H. Senderowitz, J. Sévigny, M. Munkonda, 2014, Journal of medicinal chemistry.

Applying styryl quinolinium fluorescent probes for imaging of ribosomal RNA in living cells

Y. Shav-Tal, Eli Varon, B. Fischer, 2020 .

Nucleoside-5'-phosphorothioate analogues are biocompatible antioxidants dissolving efficiently amyloid beta-metal ion aggregates.

B. Fischer, Y. Nadel, A. Amir, 2012, Dalton transactions.

Characterization of "mini-nucleotides" as P2X receptor agonists in rat cardiomyocyte cultures. An integrated synthetic, biochemical, and theoretical study.

K. Jacobson, D. Major, B. Fischer, 1999, Journal of medicinal chemistry.

Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.

D. Major, G. Reiser, M. Dixit, 2015, Journal of medicinal chemistry.

Novel Cu(I)-selective chelators based on a bis(phosphorothioyl)amide scaffold.

L. Shimon, B. Fischer, A. Amir, 2014, Inorganic Chemistry.

Boranophosphate Salts as an Excellent Mimic of Phosphate Salts: Preparation, Characterization, and Properties

B. Fischer, V. Nahum, 2004 .

Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.

J. Camden, G. Weisman, H. Barr, 2012, Journal of medicinal chemistry.

Theoretical study of the pH-dependent photophysics of n1,n6-ethenoadenine and N3,N4-ethenocytosine

D. Major, B. Fischer, 2003 .